Epidermal growth factor receptor (EGFR), one of the growth factor-binding receptors, has been demonstrated to be overexpressed in multiple epithelial human cancer cells that served as a bull’s-eye for cancer drug delivery [113,114,115]. The gene discussed is EGFR; the disease is cancer.